{"pageContent": "Purpose of review: For men newly diagnosed with prostate cancer, there are limited tools to understand the risk of disease progression and guide the treatment decision process. We will provide an overview of current prostate cancer biomarker discovery and validation strategies that are geared toward identifying aggressive, clinically significant disease at the time of diagnosis.", "metaData": {"source": "Prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/27275890/"}}